U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C122H210N32O22
Molecular Weight 2477.174
Optical Activity UNSPECIFIED
Defined Stereocenters 21 / 21
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PEXIGANAN

SMILES

CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O

InChI

InChIKey=KGZGFSNZWHMDGZ-KAYYGGFYSA-N
InChI=1S/C122H210N32O22/c1-13-77(9)102(152-98(155)71-132)120(174)135-73-100(157)139-86(50-26-35-59-125)110(164)150-96(69-82-44-20-16-21-45-82)118(172)148-93(66-74(3)4)116(170)145-90(54-30-39-63-129)113(167)142-87(51-27-36-60-126)109(163)137-79(11)105(159)141-88(52-28-37-61-127)112(166)143-91(55-31-40-64-130)114(168)149-95(68-81-42-18-15-19-43-81)107(161)134-72-99(156)138-85(49-25-34-58-124)108(162)136-80(12)106(160)147-97(70-83-46-22-17-23-47-83)119(173)153-101(76(7)8)121(175)146-92(56-32-41-65-131)115(169)154-103(78(10)14-2)122(176)151-94(67-75(5)6)117(171)144-89(53-29-38-62-128)111(165)140-84(104(133)158)48-24-33-57-123/h15-23,42-47,74-80,84-97,101-103H,13-14,24-41,48-73,123-132H2,1-12H3,(H2,133,158)(H,134,161)(H,135,174)(H,136,162)(H,137,163)(H,138,156)(H,139,157)(H,140,165)(H,141,159)(H,142,167)(H,143,166)(H,144,171)(H,145,170)(H,146,175)(H,147,160)(H,148,172)(H,149,168)(H,150,164)(H,151,176)(H,152,155)(H,153,173)(H,154,169)/t77-,78-,79-,80-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,101-,102-,103-/m0/s1

HIDE SMILES / InChI
Pexiganan is a 22-amino-acid synthetic cationic peptide. It is an analog of magainin 2, which is a host defense peptide isolated from frog skin. The drug is thought to act by disturbing the permeability of the cell membrane or cell wall. Pexiganan exhibited in vitro broad-spectrum antibacterial activity when it was tested against 3,109 clinical isolates of gram-positive and gram-negative, anaerobic and aerobic bacteria. It is currently in phase 3 clinical trials as a topical antimicrobial agent for the treatment of mild infections associated with diabetic foot ulcers. In vitro data for pexiganan acetate suggest that the drug does have hemolytic activity at concentrations relevant for antibacterial activity. In association with tigecycline, pexiganan administration could overcome antibiotic resistance and increase the effectiveness of treatment against P. aeruginosa sepsis.

Approval Year

PubMed

PubMed

TitleDatePubMed
In vitro antibacterial properties of pexiganan, an analog of magainin.
1999 Apr
In vitro spectrum of pexiganan activity when tested against pathogens from diabetic foot infections and with selected resistance mechanisms.
2015 Mar
What Is the 'Minimum Inhibitory Concentration' (MIC) of Pexiganan Acting on Escherichia coli?-A Cautionary Case Study.
2016
Efficacy of Pexiganan Combination with Tigecycline in a Mouse Model of Pseudomonas aeruginosa Sepsis.
2018

Sample Use Guides

1% cream (frequency of administration not stated)
Route of Administration: Topical
Name Type Language
PEXIGANAN
INN   MI  
INN  
Official Name English
7-L-LYSINE-8-L-LYSINE-10-L-LYSINE-18-L-LYSINE-19-DE-L-GLUTAMIC ACID-21-L-LEUCINE-23-L-LYSINAMIDE MAGAININ I
Common Name English
L-LYSINAMIDE, GLYCYL-L-ISOLEUCYLGLYCYL-L-LYSYL-L-PHENYLALANYL-L-LEUCYL-L-LYSYL-L-LYSYL-L-ALANYL-L-LYSYL-L-LYSYL-L-PHENYLALANYLGLYCYL-L-LYSYL-L-ALANYL-L-PHENYLALANYL-L-VALYL-L-LYSYL-L-ISOLEUCYL-L-LEUCYL-L-LYSYL-
Systematic Name English
PEXIGANAN [MI]
Common Name English
GLY-ILE-GLY-LYS-PHE-LEU-LYS-LYS-ALA-LYS-LYS-PHE-GLY-LYS-ALA-PHE-VAL-LYS-ILE-LEU-LYS-LYS-NH2
Common Name English
pexiganan [INN]
Common Name English
Code System Code Type Description
PUBCHEM
16132253
Created by admin on Sat Dec 16 01:22:03 GMT 2023 , Edited by admin on Sat Dec 16 01:22:03 GMT 2023
PRIMARY
INN
7671
Created by admin on Sat Dec 16 01:22:03 GMT 2023 , Edited by admin on Sat Dec 16 01:22:03 GMT 2023
PRIMARY
MERCK INDEX
m8578
Created by admin on Sat Dec 16 01:22:03 GMT 2023 , Edited by admin on Sat Dec 16 01:22:03 GMT 2023
PRIMARY Merck Index
ChEMBL
CHEMBL1275802
Created by admin on Sat Dec 16 01:22:03 GMT 2023 , Edited by admin on Sat Dec 16 01:22:03 GMT 2023
PRIMARY
CAS
147664-63-9
Created by admin on Sat Dec 16 01:22:03 GMT 2023 , Edited by admin on Sat Dec 16 01:22:03 GMT 2023
PRIMARY
NCI_THESAURUS
C170315
Created by admin on Sat Dec 16 01:22:03 GMT 2023 , Edited by admin on Sat Dec 16 01:22:03 GMT 2023
PRIMARY
EVMPD
SUB09741MIG
Created by admin on Sat Dec 16 01:22:03 GMT 2023 , Edited by admin on Sat Dec 16 01:22:03 GMT 2023
PRIMARY
FDA UNII
TVF29Q70Q1
Created by admin on Sat Dec 16 01:22:03 GMT 2023 , Edited by admin on Sat Dec 16 01:22:03 GMT 2023
PRIMARY